G07 : The phase 3 C-EDGE treatment-naïve (TN) study of a 12-week oral regimen of grazoprevir (GZR, MK-5172)/ elbasvir (EBR, MK-8742) in patients with chronic HCV genotype (GT) 1, 4, or 6 infection

@article{Zeuzem2015G07T,
  title={G07 : The phase 3 C-EDGE treatment-na{\"i}ve (TN) study of a 12-week oral regimen of grazoprevir (GZR, MK-5172)/ elbasvir (EBR, MK-8742) in patients with chronic HCV genotype (GT) 1, 4, or 6 infection},
  author={Stefan Zeuzem and Rawaa Ghalib and Karunanidhi. Reddy and Paul J. Pockros and Ziv Ben Ari and Yunlong Zhao and David Adekunle Brown and M. J. Dinubile and Michael N. Robertson and Janice Wahl and Eliav Barr and Joan R. Butterton},
  journal={Journal of Hepatology},
  year={2015},
  volume={62}
}